| |
|
|
|
Age-Related Macular Degeneration: Treatment
Description: Age-related macular degeneration (AMD) leads to dysfunction of the central retina. As the primary cause of visual disability among adults in Western societies, it affects not only patients, but also physicians, caregivers, and society. This course covers the treatment options for the wet and dry forms of AMD, discusses the complications of AMD, and describes preventive measures and currently approved treatment options.
|
COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview
COMPLICATIONS
4. Objectives
5. Dry AMD: Prognosis
6. Wet AMD: Prognosis
7. Progress Check
PREVENTION
8. Objectives
9. Vitamins
10. Other
11. Progress Check
TREATMENT
12. Objectives
13. Thermal Photocoagulation
14. Photodynamic Therapy
15. VEGF Inhibitors
16. Mechanism
17. Bevacizumab and Ranibizumab
18. Length and Efficacy of Treatment
19. Wet AMD: Combined Therapy
20. Wet AMD: Surgical Options
21. Progress Check
CONCLUSION
22. Summary
GLOSSARY/RESOURCES
|
|
COURSE OBJECTIVES
Students completing this course should be able
to:
- Describe the most common complications associated with AMD
- Understand the prognosis of wet AMD if left untreated
- Explain the role of vitamins in AMD
- List current treatment modalities for wet AMD
- Understand how the treatments for wet AMD work
|
|
|
|
 SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.
|
|